vs
Side-by-side financial comparison of Criteo S.A. (CRTO) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
Criteo S.A. is the larger business by last-quarter revenue ($482.7M vs $270.8M, roughly 1.8× HUTCHMED (China) Ltd). Criteo S.A. runs the higher net margin — 4.4% vs 0.7%, a 3.7% gap on every dollar of revenue. On growth, Criteo S.A. posted the faster year-over-year revenue change (2.4% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-36.6M).
Criteo S.A. is an advertising company that provides online display advertisements. The company was founded and is headquartered in Paris, France.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
CRTO vs HCM — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $482.7M | $270.8M |
| Net Profit | $21.3M | $2.0M |
| Gross Margin | 53.6% | 37.7% |
| Operating Margin | 6.3% | -13.2% |
| Net Margin | 4.4% | 0.7% |
| Revenue YoY | 2.4% | -16.5% |
| Net Profit YoY | -21.3% | -83.6% |
| EPS (diluted) | $0.39 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $270.8M | ||
| Q2 25 | $482.7M | $277.7M | ||
| Q1 25 | $451.4M | $324.5M | ||
| Q4 24 | $553.0M | — | ||
| Q3 24 | $458.9M | — | ||
| Q2 24 | $471.3M | $305.7M | ||
| Q1 24 | $450.1M | — | ||
| Q4 23 | $566.3M | — |
| Q4 25 | — | $2.0M | ||
| Q2 25 | $21.3M | $455.0M | ||
| Q1 25 | $37.9M | $11.9M | ||
| Q4 24 | $71.1M | — | ||
| Q3 24 | $6.2M | — | ||
| Q2 24 | $27.0M | $25.8M | ||
| Q1 24 | $7.2M | — | ||
| Q4 23 | $61.0M | — |
| Q4 25 | — | 37.7% | ||
| Q2 25 | 53.6% | 0.1% | ||
| Q1 25 | 52.5% | 48.0% | ||
| Q4 24 | 54.4% | — | ||
| Q3 24 | 50.5% | — | ||
| Q2 24 | 49.4% | 41.1% | ||
| Q1 24 | 48.3% | — | ||
| Q4 23 | 48.8% | — |
| Q4 25 | — | -13.2% | ||
| Q2 25 | 6.3% | -1.3% | ||
| Q1 25 | 10.7% | -5.0% | ||
| Q4 24 | 17.1% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 7.8% | -9.0% | ||
| Q1 24 | 2.3% | — | ||
| Q4 23 | 15.6% | — |
| Q4 25 | — | 0.7% | ||
| Q2 25 | 4.4% | 163.8% | ||
| Q1 25 | 8.4% | 3.7% | ||
| Q4 24 | 12.9% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 5.7% | 8.4% | ||
| Q1 24 | 1.6% | — | ||
| Q4 23 | 10.8% | — |
| Q4 25 | — | $0.00 | ||
| Q2 25 | $0.39 | $0.52 | ||
| Q1 25 | $0.66 | $0.01 | ||
| Q4 24 | $1.21 | — | ||
| Q3 24 | $0.11 | — | ||
| Q2 24 | $0.46 | $0.03 | ||
| Q1 24 | $0.12 | — | ||
| Q4 23 | $1.02 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $223.6M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $1.1B | $1.2B |
| Total Assets | $2.1B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.4B | ||
| Q2 25 | $223.6M | $1.4B | ||
| Q1 25 | $313.2M | $836.1M | ||
| Q4 24 | $316.9M | — | ||
| Q3 24 | $231.8M | — | ||
| Q2 24 | $233.2M | $802.5M | ||
| Q1 24 | $278.1M | — | ||
| Q4 23 | $342.3M | — |
| Q4 25 | — | $93.2M | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | — | $1.2B | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | $1.1B | $759.9M | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | $740.1M | ||
| Q1 24 | $1.0B | — | ||
| Q4 23 | $1.1B | — |
| Q4 25 | — | $1.8B | ||
| Q2 25 | $2.1B | $1.8B | ||
| Q1 25 | $2.1B | $1.3B | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.2B | $1.3B | ||
| Q1 24 | $2.2B | — | ||
| Q4 23 | $2.4B | — |
| Q4 25 | — | 0.08× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $8.2M |
| Free Cash FlowOCF − Capex | $-36.6M | $3.4M |
| FCF MarginFCF / Revenue | -7.6% | 1.2% |
| Capex IntensityCapex / Revenue | 7.3% | 1.8% |
| Cash ConversionOCF / Net Profit | -0.07× | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.2M | ||
| Q2 25 | $-1.4M | $-72.9M | ||
| Q1 25 | $62.3M | $40.3M | ||
| Q4 24 | $169.5M | — | ||
| Q3 24 | $57.5M | — | ||
| Q2 24 | $17.2M | $-39.8M | ||
| Q1 24 | $14.0M | — | ||
| Q4 23 | $161.3M | — |
| Q4 25 | — | $3.4M | ||
| Q2 25 | $-36.6M | $-82.2M | ||
| Q1 25 | $45.3M | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-4.0M | $-49.9M | ||
| Q1 24 | $173.0K | — | ||
| Q4 23 | — | — |
| Q4 25 | — | 1.2% | ||
| Q2 25 | -7.6% | -29.6% | ||
| Q1 25 | 10.0% | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.9% | -16.3% | ||
| Q1 24 | 0.0% | — | ||
| Q4 23 | — | — |
| Q4 25 | — | 1.8% | ||
| Q2 25 | 7.3% | 3.3% | ||
| Q1 25 | 3.8% | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.5% | 3.3% | ||
| Q1 24 | 3.1% | — | ||
| Q4 23 | — | — |
| Q4 25 | — | 4.21× | ||
| Q2 25 | -0.07× | -0.16× | ||
| Q1 25 | 1.64× | 3.38× | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 9.21× | — | ||
| Q2 24 | 0.64× | -1.54× | ||
| Q1 24 | 1.93× | — | ||
| Q4 23 | 2.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRTO
| Commerce Growth | $393.9M | 82% |
| Retail Media | $60.9M | 13% |
| Other | $27.9M | 6% |
HCM
Segment breakdown not available.
